Home therapy for hemophilia
Weinger, R.S.; Cimo, P.L.
Texas Medicine 74(6): 57-60
1978
ISSN/ISBN: 0040-4470 PMID: 663856 Document Number: 136466
Document emailed within 1 workday
Related Documents
Jones, P. 1979: Organization of hemophilia therapy. the role of the hemophilia center Sangre 24(5-C): 998-1004Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483
Saito, N. 1998: Home-oxygen therapy and QOL support for the in the home setting patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(Suppl 4): 511-514
Perruchoud, A. 1982: Introduction and guidelines for oxygen home therapy and for home respirators Schweizerische Rundschau für Medizin Praxis 71(8): 337-342
Hutaff, L.W. 1973: Specific therapy in hemophilia North Carolina Medical Journal 34(3): 193-196
Kurachi, K.; Yao, S.N. 1993: Gene therapy of hemophilia B Thrombosis and Haemostasis 70(1): 193-197
Hilgartner, M.W. 1984: Complications of therapy in hemophilia Pediatrics 74(2): 290-291
Lillicrap, D.P.; Bridge, P.J.; Giles, A.R. 1990: Organization of a hemophilia genetic screening program. Ontario Hemophilia Study Group Progress in Clinical and Biological Research 324: 19-28
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Chao, H.; Walsh, C.E. 2004: AAV vectors for hemophilia B gene therapy Mount Sinai Journal of Medicine new York 71(5): 305-313
Brdicka, R. 2001: Gene therapy of hemophilia--the next disappointment? Casopis lekaru ceskych 140(20): 640-641
Nowak, K.; Zalewska-Szewczyk, B.; Stolarska, M.; Bodalski, J. 1994: Prophylactic replacement therapy of hemophilia Polski Tygodnik Lekarski 49(12-13): 271-272
Nichols, S.; Mahoney, E.M.; Sirois, P.A.; Bordeaux, J.D.; Stehbens, J.A.; Loveland, K.A.; Amodei, N. 2000: HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the Hemophilia Growth and Development Study Journal of Pediatric Psychology 25(8): 545-556
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Girolami, A.; Dal Bo Zanon, R.; Procidano, M. 1981: Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1 Folia Haematologica 108(6): 863-871
Carasso, Y.; Hoffman, R.; Keren-Politansky, A.; Brenner, B.; Nadir, Y. 2019: Acquired Hemophilia a and the Timing of Immunomodulatory Therapy Harefuah 158(3): 165-167
Schmitz, J.E.; Süssenbach, F. 1971: Conservative orthopedic principles in the therapy of hemophilia Medizinische Klinik 66(36): 1209-1211
Allain, J.P. 1979: Dose requirement for replacement therapy in hemophilia a Thrombosis and Haemostasis 42(3): 825-831
Mandelli, F. 1973: Current therapy of hemophilia and other congenital coagulopathies Professioni Infermieristiche 26(3): 68-72